Ionis Pharmaceuticals, Inc.
MODULATION OF GYS1 EXPRESSION
Last updated:
Abstract:
Provided herein are methods, compounds, and compositions for reducing expression of GYS1 in an individual. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate a glycogen storage disease or disorder in an individual in need.
Status:
Application
Type:
Utility
Filling date:
23 Dec 2021
Issue date:
14 Apr 2022